.
https://emedicine.medscape.com/artic...7343&faf=1&#a2
I would recommend the
Ad26.COV2.S
Neutralizing antibodies against SARS-CoV-2 were detected at day 29 in 90% or more of all participants, regardless of vaccine dose or age group, and reached 100% by day 57; strong T-cell responses and a T H1 response were also noted [13]


https://emedicine.medscape.com/artic...7343&faf=1&#a2
I would recommend the
Ad26.COV2.S
Neutralizing antibodies against SARS-CoV-2 were detected at day 29 in 90% or more of all participants, regardless of vaccine dose or age group, and reached 100% by day 57; strong T-cell responses and a T H1 response were also noted [13]
Comment